223 related articles for article (PubMed ID: 31874511)
1. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
2. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
[No Abstract] [Full Text] [Related]
3. Targeted long-read sequencing for comprehensive detection of CYP21A2 mutations in patients with 21-hydroxylase deficiency.
Zhang X; Gao Y; Lu L; Cao Y; Zhang W; Sun B; Wu X; Tong A; Chen S; Wang X; Mao J; Nie M
J Endocrinol Invest; 2024 Apr; 47(4):833-841. PubMed ID: 37815751
[TBL] [Abstract][Full Text] [Related]
4. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.
Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB
Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666
[TBL] [Abstract][Full Text] [Related]
5. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency.
Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z
Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of multiplex ligation dependent probe amplification combined with Sanger sequencing in 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Tong AL; Chen S; Mao JF; Wang X; Wu XY; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):432-437. PubMed ID: 30786337
[No Abstract] [Full Text] [Related]
8. [Molecular and clinical study on homozygous or heterozygous large deletion of
Gao YJ; Yu BQ; Lu L; Tong AL; Chen S; Mao JF; Wang X; Wu XY; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):912-917. PubMed ID: 30917440
[No Abstract] [Full Text] [Related]
9. Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia.
Vrzalová Z; Hrubá Z; Hrabincová ES; Vrábelová S; Votava F; Koloušková S; Fajkusová L
Eur J Med Genet; 2011; 54(2):112-7. PubMed ID: 20970527
[TBL] [Abstract][Full Text] [Related]
10. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
[TBL] [Abstract][Full Text] [Related]
11. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
[TBL] [Abstract][Full Text] [Related]
12. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
[TBL] [Abstract][Full Text] [Related]
13. Long-read sequencing: An effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia.
Li H; Zhu X; Yang Y; Wang W; Mao A; Li J; Bao S; Li J
Clin Chim Acta; 2023 Jul; 547():117419. PubMed ID: 37276943
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
15. Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Chen W; Xu Z; Nishitani M; Van Ryzin C; McDonnell NB; Merke DP
Hum Genet; 2012 Dec; 131(12):1889-94. PubMed ID: 22886582
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of congenital adrenal hyperplasia.
Cantürk C; Baade U; Salazar R; Storm N; Pörtner R; Höppner W
Clin Chem; 2011 Mar; 57(3):511-7. PubMed ID: 21148302
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
Xu Z; Chen W; Merke DP; McDonnell NB
J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
[TBL] [Abstract][Full Text] [Related]
18. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
20. Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency.
Vrzalová Z; Hrubá Z; St'ahlová Hrabincová E; Pouchlá S; Votava F; Kolousková S; Fajkusová L
Int J Mol Med; 2010 Oct; 26(4):595-603. PubMed ID: 20818501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
